Predictors of hypoglycemia in the ASPIRE in-home study and effects of automatic suspension of insulin delivery

Journal of Diabetes Science and Technology

Volumn 9, Issue 5, 2015, Pages 1016-1020

  Weiss, Ram ^a,j   Garg, Satish K ^b   Bergenstal, Richard M ^c   Klonoff, David C ^d   Bode, Bruce W ^e   Bailey, Timothy S ^f   Thrasher, James ^g   Schwartz, Frank ^h   Welsh, John B ⁱ   Kaufman, Francine R ⁱ  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF COLORADO   (United States)

^c INTERNATIONAL DIABETES CENTER   (United States)

^d Mills Peninsula Health Services   (United States)

^e ATLANTA DIABETES ASSOCIATES   (United States)

^f AMCR Institute   (United States)

^g Arkansas Diabetes and Endocrinology Center   (United States)

^h OHIO UNIVERSITY   (United States)

ⁱ MEDTRONIC INC   (United States)

^j HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

more..

Author keywords

Aspire in home; Hypoglycemia; Low glucose suspend; Prediction; Sensor augmented pump therapy; Threshold suspend

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ARTICLE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG DELIVERY SYSTEM; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; MAJOR CLINICAL STUDY; NOCTURNAL HYPOGLYCEMIA; REGRESSION ANALYSIS; ANALYSIS; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN INFUSION; MALE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 85016650133     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815586014     Document Type: Article

References (17)

1. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013; 369:224-232.
2. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol. 2011; 5:1137-1141.
3. Agrawal P, Zhong A, Welsh JB, Shah R, Kaufman FR. Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther. 2015; 17:316-319.
4. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011; 34:2023-2025.
5. Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011; 13:1129-1134.
6. Brazg RL, Bailey TS, Garg S, et al. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. J Diabetes Sci Technol. 2011; 5:1466-1471.
7. Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012; 14: 205-209.
8. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013; 310:1240-1247.
9. Wilson DM, Calhoun PM, Maahs DM, et al. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes [published online ahead of print March 11, 2015]. Diabetes Technol Ther. doi:10.1089/dia.2014.0342.
10. Klonoff DC, Bergenstal RM, Garg SK, et al. ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol. 2013; 7:1005-1010.
11. Blasetti A, Di Giulio C, Tocco AM, et al. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study. Pediatr Diabetes. 2011; 12:4-10.
12. Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013; 14:447-454.
13. Johansen A, Kanijo B, Fredheim S, et al. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes [published online ahead of print July 12, 2014]. Pediatr Diabetes. doi:10.1111/pedi.12171.
14. Ramotowska A, Golicki D, Dzygalo K, Szypowska A. The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus-systematic review. Exp Clin Endocrinol Diabetes. 2013; 121:248-254.
15. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363:311-320.
16. Tanenberg RJ, Welsh JB. Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the star 3 study. Endocr Pract. 2015; 21:41-45.
17. Awoniyi O, Rehman R, Dagogo-Jack S. Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention. Curr Diab Rep. 2013; 13:669-678.